. 2023 Jan 20;42(1):16-26. doi: 10.5937/jomb0-37234

Table 2. Demographic and clinical characteristics of the patients.

WHO, World Health Organization; ICU, intensive care unit; DM, diabetes mellitus, HT, hypertension; CAD, coronary artery disease; COPD, chronic obstructive lung disease; CLD, chronic liver disease; CKD, chronic kidney disease; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CK, creatine kinase; LDH, lactate dehydrogenase; CT, computed tomography. ^† Moderate disease defined as a WHO score of ≤5. ^‡Severe disease is defined as a WHO score of ≥6 (ICU admission or death).

	Moderate disease^†<br>(n = 65)	Severe disease^‡<br>(n = 46)	All patients<br>(n = 111)	p-value
Age	57.54 ± 16.26	63.39 ± 15.50	59.96 ± 16.14	0.059
Gender (female)	27 (41.54%)	16 (34.78%)	43 (38.74%)	0.472
Symptoms at admission<br>Respiratory symptoms<br>Gastrointestinal symptoms<br>Myalgia	<br>40 (61.54%)<br>8 (12.31%)<br>13 (20.00%)	<br>38 (82.61%) <br>3 (6.52%) <br>3 (6.52%)	<br>78 (70.27%) <br>11 (9.91%) <br>16 (14.41%)	<br>0.017 <br>0.357 <br>0.046
Length of hospital stay (days)	11 (4–37)	19 (5–115)	13 (4–115)	<0.001
Co-morbidities<br>DM (yes)<br>HT (yes)<br>CAD (yes)<br>COPD (yes)<br>CKD (yes)	<br>11 (16.92%)<br>23 (35.38%)<br>6 (9.23%)<br>6 (9.23%)<br>3 (4.61%)	<br>16 (34.78%)<br>22 (47.83%)<br>10 (21.74%)<br>2 (4.35%)<br>7 (15.22%)	<br>27 (24.32%)<br>45 (40.54%)<br>16 (14.41%)<br>8 (7.21%)<br>10 (9.01)	<br>0.031<br>0.188<br>0.065<br>0.466<br>0.089
Laboratory results on the test day<br>LDH (U/L)<br>Lymphocyte count (10³/mL)<br>Lymphocyte percentage (%)<br>AST (U/L)<br>ALT (U/L)<br>CK (U/L)<br>Troponin I (ng/L)<br>Ferritin (mg/L)<br>Total bilirubin (mg/dL)<br>Direct bilirubin (mg/dL)	<br>311 (243–624)<br>1100 (300–3000)<br>19 (2.80–50)<br>36 (14–215)<br>30 (10–218)<br>74 (13–2031)<br>9.35 (3–589) n:42<br>370.50 (10–1850) n:58<br>0.60 (0.27–1.60)<br>0.10 (0.01–0.40)	<br>411.50 (281–881)<br>900 (100–2000)<br>14.50 (1.40–86)<br>57.50 (19–298)<br>45.50 (8–269)<br>79.50 (14–1143)<br>16 (3–500) n:45<br>461.50 (10–3689)<br>0.60 (0.18–3.37)<br>0.10 (0.01–2.44)	<br>350 (243–881)<br>1000 (100–3000)<br>17 (1.4–86)<br>39 (14–298)<br>36 (8–269)<br>75 (13–2031)<br>12 (3–589)<br>388 (10–3689)<br>0.6 (0.18–3.37)<br>0.1 (0.01–2.44)	<br><0.001<br>0.004<br>0.002<br><0.001<br>0.071<br>0.720<br>0.014<br>0.076<br>0.891
LDH isoenzymes<br>LDH1 (U/L)<br>LDH2 (U/L)<br>LDH3 (U/L)<br>LDH4 (U/L)<br>LDH5 (U/L)	<br>63.42 (41.65–141.65)<br>106.80 (39.53–219.45)<br>70.18 (29.07–151.63)<br>31.84 (12.97–71.20)<br>39.30 (13.54–217.55)	<br>83.25 (37.65–189.06)<br>142.09 (73.75–292.41)<br>91.29 (53.39–246.68)<br>43.24 (15.81–117.11)<br>48.92 (10.22–191.27)	<br>70.22 (37.65–189.06)<br>117.42 (39.53–292.41)<br>81.34 (29.07–246.68)<br>34.51 (12.97–117.11)<br>43 (10.22–217.55)	<br><0.001<br><0.001<br><0.001<br><0.001<br>0.024
Chest CT score<br>(0–25)	9 (1–21)	15 (5–25)	11 (1–25)	<0.001